Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic cancer vaccines
Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 360-378
Closed Access | Times Cited: 1082

Showing 1-25 of 1082 citing articles:

Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl, Chien‐Huan Weng, Shabnam Eghbali, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 37-50
Closed Access | Times Cited: 585
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 481
Emerging therapies for glioblastoma: current state and future directions
Rong Liang, Ni Li, Zhenzhen Zhang
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 308
Exploring immunotherapy in colorectal cancer
Junyong Weng, Shanbao Li, Zhonglin Zhu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 221
Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao, et al.
Chemical Reviews (2024) Vol. 124, Iss. 9, pp. 5505-5616
Closed Access | Times Cited: 217
Current approaches of nanomedicines in the market and various stage of clinical translation
Xiaoting Shan, Xiang Gong, Jie Li, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3028-3048
Open Access | Times Cited: 208
Therapeutic cancer vaccines: advancements, challenges and prospects
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment
Faezzah Baharom, Ramiro A. Ramirez-Valdez, Ahad Khalilnezhad, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4317-4332.e15
Open Access | Times Cited: 152
Targeting mutations in cancer
Michael R. Waarts, Aaron J. Stonestrom, Young C. Park, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 8
Open Access | Times Cited: 145
Clinical cancer immunotherapy: Current progress and prospects
Chenglong Liu, Mengxuan Yang, Daizhou Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 145
Immunotherapy for glioblastoma: the promise of combination strategies
Mathilde Bausart, Véronique Préat, Alessio Malfanti
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 144
Thermal immuno-nanomedicine in cancer
Zhe Yang, Di Gao, Jing Zhao, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 116-134
Closed Access | Times Cited: 143
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 123
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Yunhao Wang, Qingfu Zhao, Binyu Zhao, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 103
mRNA cancer vaccines: Advances, trends and challenges
Qing He, Hua Gao, Tan De-jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2969-2989
Open Access | Times Cited: 96
The promising interplay between sonodynamic therapy and nanomedicine
Roberto Canaparo, Federica Foglietta, Nadia Barbero, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114495-114495
Closed Access | Times Cited: 95
mRNA vaccines for cancer immunotherapy
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 95
Photon-Controlled Pyroptosis Activation (PhotoPyro): An Emerging Trigger for Antitumor Immune Response
Mingle Li, Jungryun Kim, Hyeonji Rha, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 11, pp. 6007-6023
Closed Access | Times Cited: 87
Bioorthogonal-Activated In Situ Vaccine Mediated by a COF-Based Catalytic Platform for Potent Cancer Immunotherapy
Mengyu Sun, Zhengwei Liu, Li Wu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 9, pp. 5330-5341
Closed Access | Times Cited: 84
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
Di Huang, Xiao‐Feng Zhu, Shuying Ye, et al.
Nature (2023) Vol. 625, Iss. 7995, pp. 593-602
Closed Access | Times Cited: 84
Tumor–Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma
Xiaoyue Ma, Lei Kuang, Ying Yin, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2341-2355
Closed Access | Times Cited: 83
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 83
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
Chenchao Feng, Peng Tan, Guangjun Nie, et al.
Exploration (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 79
Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4
Pratibha Pandey, Fahad Khan, Huda A. Qari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 335-335
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top